M&A NEWS

PAI Partners agrees to buy ELEMIS from L'Occitane

The private equity firm takes on a Pro-Collagen brand whose sales nearly doubled to more than US$300m under L'Occitane, with half now coming from the US.

M&A News deals deskConsumer / Prestige skincare · United Kingdom, Europe4 Nov 2026

PAI Partners has agreed to acquire ELEMIS, the British prestige skincare brand, from L'Occitane Group, the two companies said on 4 November 2026. Financial terms were not disclosed.

Why PAI Partners is buying ELEMIS

PAI said it would work with the ELEMIS management team to strengthen the brand's position in the UK, accelerate expansion in the US, pursue selected international markets and grow digital and premium retail channels, while continuing to invest in the Pro-Collagen franchise and product innovation and preserving the brand's spa heritage. L'Occitane described the sale as a disciplined portfolio decision.

“ELEMIS has played a special role in the history of our Group.”Reinold Geiger, Chairman and CEO, L'Occitane Group

Deal terms and financing

No price was disclosed. Completion is expected in the first quarter of 2027, subject to customary regulatory approvals and closing conditions.

Regulatory approvals and timing

The deal requires customary regulatory approvals.

Market context

ELEMIS was founded in 1989 and was acquired by L'Occitane in 2019 from Steiner Leisure, an L Catterton portfolio company, for up to US$900m. Its net sales exceeded US$300m in fiscal 2026, with the US accounting for about half and online channels for nearly half. PAI already controls Beautynova, an Italian professional haircare group.

More United Kingdom M&A news

All United Kingdom deals →